Cargando…

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma

BACKGROUND/AIMS: Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is often asymptomatic and can go undiagnosed for years, leading to underuse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yi-Te, Karim, Mohammad A., Kum, Hye Chung, Park, Sulki, Rich, Nicole E., Noureddin, Mazen, Singal, Amit G., Yang, Ju Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121289/ https://www.ncbi.nlm.nih.gov/pubmed/36726052 http://dx.doi.org/10.3350/cmh.2022.0450

Ejemplares similares

Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis
por: Karim, Mohammad A., et al.
Publicado: (2023)

Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma
por: Wagle, Nikita Sandeep, et al.
Publicado: (2021)

Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
por: Teng, Pai-Chi, et al.
Publicado: (2023)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
por: Marquardt, Patrick, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease‐related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma
por: Bertot, Luis C., et al.
Publicado: (2017)

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response
por: Osho, Azeez, et al.
Publicado: (2020)

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
por: Goossens, Nicolas, et al.
Publicado: (2017)

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
por: Singal, Amit G., et al.
Publicado: (2014)

Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients
por: Vaz, Juan, et al.
Publicado: (2022)

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
por: Nguyen, Mindie H., et al.
Publicado: (2022)

Real-World Adherence and Effectiveness of Remote Patient Monitoring Among Medicaid Patients With Diabetes: Retrospective Cohort Study
por: Park, Sulki, et al.
Publicado: (2023)

Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
por: Zelber-Sagi, Shira, et al.
Publicado: (2021)

Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis
por: Dong, Tien S., et al.
Publicado: (2021)

Diet Quality Association with Nonalcoholic Fatty Liver Disease by Cirrhosis Status: The Multiethnic Cohort
por: Park, Song-Yi, et al.
Publicado: (2020)

Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact
por: Govalan, Rajalakshmi, et al.
Publicado: (2021)

Health services utilization, out‐of‐pocket expenditure, and underinsurance among insured non‐elderly cancer survivors in the United States, 2011–2015
por: Karim, Mohammad A., et al.
Publicado: (2021)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Daher, Darine, et al.
Publicado: (2023)

Adherence to Telemonitoring Therapy for Medicaid Patients With Hypertension: Case Study
por: Park, Sulki, et al.
Publicado: (2021)

Correction: Adherence to Telemonitoring Therapy for Medicaid Patients With Hypertension: Case Study
por: Park, Sulki, et al.
Publicado: (2022)

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
por: Ioannou, George N., et al.
Publicado: (2020)

Deep learning in hepatocellular carcinoma: Current status and future perspectives
por: Ahn, Joseph C, et al.
Publicado: (2021)

Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge
por: Steggerda, Justin A, et al.
Publicado: (2020)

Is hepatocellular carcinoma surveillance in high-risk populations effective?
por: Onyirioha, Kristeen, et al.
Publicado: (2020)

Hyponatremia in Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
por: Gutierrez Reyes, Cristian D., et al.
Publicado: (2021)

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study
por: Lapointe-Shaw, Lauren, et al.
Publicado: (2018)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
por: He, Michelle Junyi, et al.
Publicado: (2022)

A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
por: Wang, Mengjun, et al.
Publicado: (2022)

Unrecognized Cystocele
Publicado: (1830)

The Unrecognized Chancre
Publicado: (1902)

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Kassab, Ihab, et al.
Publicado: (2023)

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2016)

The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma
por: Hammam, Olfat, et al.
Publicado: (2012)

Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
por: Zanetto, Alberto, et al.
Publicado: (2021)

Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
por: Shin, Sangdeok, et al.
Publicado: (2020)

Overflow proteinuria as a manifestation of unrecognized polymyositis
por: Kim, Hyun Ho, et al.
Publicado: (2014)

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
por: Hanouneh, Ibrahim A., et al.
Publicado: (2019)

Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
por: Yeo, Yee Hui, et al.
Publicado: (2023)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_krsg892hb7g0flqv52l30ha87r